Atsushi Shinohara

Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: ⁶⁴Cu- and ²²⁵Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models

Tadashi Watabe, Yuwei Liu, Kazuko Kaneda‐Nakashima et al. · Journal of Nuclear Medicine · 2019 · 303 citations · Full text

Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model

Yuwei Liu, Tadashi Watabe, Kazuko Kaneda‐Nakashima et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 168 citations · Full text

Enhancement of²¹¹At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted α-Therapy of Thyroid Cancer

Tadashi Watabe, Kazuko Kaneda‐Nakashima, Yuwei Liu et al. · Journal of Nuclear Medicine · 2019 · 90 citations · Full text

Heterogeneous distribution of radiocesium in aerosols, soil and particulate matters emitted by the Fukushima Daiichi Nuclear Power Plant accident: retention of micro-scale heterogeneity during the migration of radiocesium from the air into ground and river systems

Kazuya Tanaka, Aya Sakaguchi, Yutaka Kanai et al. · Journal of Radioanalytical and Nuclear Chemistry · 2012 · 74 citations

Environmental Radiochemistry, Engineering, Environmental Engineering +9

Targeted alpha therapy using astatine (211At)-labeled phenylalanine: A preclinical study in glioma bearing mice

Tadashi Watabe, Kazuko Kaneda‐Nakashima, Yoshifumi Shirakami et al. · Oncotarget · 2020 · 55 citations · Full text